If you’ve been diagnosed with asthma or are experiencing respiratory symptoms, your doctor might recommend a Fractional Exhaled Nitric Oxide (FeNO) test. This non-invasive procedure measures the level of nitric oxide gas in your breath, which serves as a valuable marker for airway inflammation.
FeNO testing provides healthcare providers with critical information to accurately diagnose and manage asthma by quantifying inflammation that may not be detectable through other standard tests.
At Gwinnett Pulmonary, the FeNO test is quick and straightforward. You only need to breathe into a specialized mouthpiece connected to a monitoring device.
The results appear immediately on the monitor screen. This allows your pulmonologist to assess your airway health during your appointment.
This direct measurement helps distinguish between different types of respiratory conditions. It guides personalized treatment decisions.
FeNO testing is a non-invasive diagnostic procedure that measures the concentration of nitric oxide in exhaled breath to assess airway inflammation. This valuable tool helps clinicians diagnose and manage respiratory conditions, particularly asthma, with greater precision than traditional methods.
Fractional Exhaled Nitric Oxide (FeNO) refers to measuring nitric oxide gas in your breath when you exhale. Nitric oxide, including the lungs and airways, is naturally produced in your body.
When inflammation is present in your airways, particularly those associated with allergic or eosinophilic asthma, your body produces higher nitric oxide levels. This increase makes nitric oxide an excellent biomarker for detecting and monitoring airway inflammation.
The FeNO test specifically measures this gas in parts per billion (ppb), providing quantifiable data about inflammation levels.
Higher readings typically indicate more significant inflammation. Lower readings suggest less inflammation or well-controlled asthma.
FeNO testing serves multiple vital purposes in respiratory care. It helps diagnose asthma by identifying airway inflammation that might not be detected through other tests.
For patients with existing asthma diagnoses, FeNO testing helps monitor the effectiveness of their treatment. Decreasing FeNO levels often indicate that anti-inflammatory medications are working properly.
The test can also predict potential asthma exacerbations before symptoms worsen. Rising FeNO levels may signal the need for treatment adjustments to prevent asthma attacks.
Additionally, FeNO testing helps distinguish between different asthma phenotypes. This allows for more personalized treatment approaches.
It’s instrumental in identifying patients who might respond well to specific medications, such as inhaled corticosteroids.
FeNO testing offers several advantages over conventional asthma testing methods. Unlike spirometry, which measures airflow limitations, FeNO directly assesses underlying inflammation, the root cause of asthma symptoms.
The test is completely non-invasive, requiring only normal breathing into a device. This makes it suitable for patients of various ages and abilities, including children and those who struggle with spirometry maneuvers.
Results are available immediately. This allows for on-the-spot clinical decisions rather than waiting for laboratory analysis.
This real-time feedback enables prompt adjustments to treatment when necessary. FeNO testing demonstrates superior sensitivity in detecting airway inflammation even when lung function appears normal.
This helps identify patients who might be at risk despite showing no apparent symptoms during examination.
FeNO testing is a straightforward, non-invasive procedure that measures the level of nitric oxide in your exhaled breath to assess airway inflammation. The process typically takes less than 10 minutes to complete and provides valuable data for diagnosing and managing asthma.
You should avoid eating or drinking for at least 1 hour before your FeNO test. Nitrate-rich foods, such as leafy greens, can temporarily increase nitric oxide levels, which may affect the results.
Inform your healthcare provider about medications, particularly corticosteroids, as they can lower FeNO readings. Your provider may ask you to discontinue certain medications temporarily before testing.
Strenuous exercise should be avoided for at least 1 hour before the test. You should also refrain from smoking for at least 1 hour before testing, as smoking can artificially alter nitric oxide levels.
You’ll be seated comfortably and provided with a handheld device featuring a disposable mouthpiece. The technician will guide you through the proper technique.
First, you’ll take a deep breath through the mouthpiece, filling your lungs. Then, you’ll exhale slowly and steadily into the device at a controlled rate.
The device usually provides visual feedback to help maintain the correct exhalation speed. The test typically requires 10 seconds of consistent exhalation.
Most protocols recommend performing the test twice to ensure accuracy and reliability. The final result is the average of the readings.
FeNO results are measured in parts per billion (ppb) and are available immediately after testing. Normal FeNO levels are typically below 25 ppb in adults and below 20 ppb in children.
Readings between 25 and 50 ppb indicate intermediate inflammation. Levels above 50 ppb suggest significant airway inflammation, often associated with allergic asthma.
Your healthcare provider will interpret these results in context with your symptoms and medical history. Higher FeNO levels may indicate poor response to current asthma treatment or exposure to allergens.
Consistently high readings despite treatment might prompt your doctor to adjust your medication regimen or investigate potential triggers.
FeNO testing has become an essential diagnostic tool in modern respiratory care. The test’s non-invasive nature and immediate results make it valuable for clinicians and patients seeking answers about inflammatory airway conditions.
FeNO testing plays a crucial role in asthma management by measuring nitric oxide levels in exhaled breath. This biomarker directly correlates with eosinophilic airway inflammation, a key component in allergic asthma.
When your FeNO levels are elevated, it typically indicates active inflammation that may require adjustment to your treatment plan. Doctors at Gwinnett Pulmonary use these measurements to make informed decisions about initiating or modifying corticosteroid therapy.
The test helps differentiate between asthma and other respiratory conditions with similar symptoms. Regular FeNO monitoring can help predict and prevent exacerbations for patients already diagnosed with asthma.
This allows for proactive treatment adjustments before symptoms worsen.
FeNO testing may be beneficial if you experience unexplained respiratory symptoms such as persistent cough, wheezing, or shortness of breath. This test is particularly valuable if you have suspected asthma but inconclusive spirometry results.
Patients with known asthma can use FeNO testing to monitor the stability of their condition and the effectiveness of their treatment. The test is beneficial for individuals with asthma triggered by allergies, as it detects increases in nitric oxide production in response to allergen exposure.
FeNO testing also helps differentiate conditions, such as acute eosinophilic pneumonia, in patients with fever and pulmonary infiltrates. This non-invasive test is safe for children with respiratory symptoms and is suitable for patients of various ages.
At Gwinnett Pulmonary, your FeNO testing experience is straightforward and comfortable. Upon arrival, a respiratory specialist will explain the simple procedure and answer any questions you may have.
The test requires you to exhale steadily into a handheld device for about 10 seconds. You’ll need to maintain a constant exhalation pressure, guided by visual feedback on the device’s screen.
After a brief demonstration, most patients find this process easy to complete. The procedure takes only a few minutes, and results are available immediately.
Your doctor will interpret these results during the same visit. They will discuss your specific nitric oxide levels related to respiratory health and develop a personalized treatment plan tailored to your needs.
While FeNO testing provides valuable insights into airway inflammation, it’s essential to understand its limitations and when it may not provide complete information for asthma management decisions.
Certain medications can significantly impact FeNO results. Corticosteroids typically reduce nitric oxide levels, potentially leading to falsely low readings if you’re currently using these medications.
Recent food intake, particularly nitrate-rich foods such as leafy greens, may temporarily increase FeNO levels. Smoking can also affect results, as it can artificially lower nitric oxide readings.
Your age, height, and sex can influence a normal FeNO range. Children and adolescents often have different baseline levels than adults.
Upper respiratory infections can temporarily increase FeNO readings, which may confuse the interpretation of results if you’re currently sick.
FeNO testing is most effective in evaluating asthma associated with allergies or eosinophilia.
Additional testing methods may be necessary to obtain a complete picture if you have non-allergic asthma or other respiratory conditions.
For patients with severe airflow obstruction (FEV1 < 40%), FeNO testing can be challenging to perform correctly.
This might yield less reliable results.
Young children (typically under 5 years) may struggle to perform the breathing maneuver correctly.
This makes results less dependable in this age group.
If your symptoms don’t align with FeNO results, your doctor might recommend spirometry or bronchoprovocation testing.
Sputum analysis may also be used to gain a better understanding of your condition.
FeNO testing is a quick, painless, and highly effective method for detecting airway inflammation and guiding asthma treatment. It provides real-time insights beyond traditional lung function tests, making it a vital tool for accurate diagnosis and personalized care. Whether managing asthma or seeking answers for ongoing respiratory symptoms, FeNO testing empowers patients and physicians to take proactive steps toward better health.
Think FeNO testing might benefit you? Book an appointment with Gwinnett Pulmonary & Sleep for expert testing, immediate results, and a personalized care plan tailored to your respiratory needs.
Plugin powered by Kapsule Corp
